India - Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases
Since 2014, India Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases jumped by 20.8% year on year. In 2019, the country was number 1 comparing other countries in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases with 66,255 Cases. India, Russia and Russia respectively ranked number 2, 3 and 4 in this ranking. Republic of the Congo witnessed the best average annual growth at +171.1% per year, while Croatia recorded the worst performance at -100% per year.
Loading...
| Date | Units (Cases) |
|---|---|
| 2019 | 66,255.00 |
| 2018 | 58,347.00 |
| 2017 | 39,009.00 |
| 2016 | 37,258.00 |
| 2015 | 28,876.00 |
Download all data from 2005 to 2019
How does India rank in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases?
| # | 359 Countries | Units (Cases) | Last | YoY | 5‑years CAGR | |
|---|---|---|---|---|---|---|
| 1 |
#1
India
|
66,255 | 2019 | +13.6 % | +20.8 % | View data |
| 3 |
#3
Russia
|
29,181 | 2019 | +5.0 % | +13.4 % | View data |
| 5 |
#5
China
|
18,246 | 2019 | +24.7 % | +25.7 % | View data |
| 6 |
#6
South Africa
|
18,080 | 2019 | +2.1 % | -0.7 % | View data |
| 9 |
#9
Indonesia
|
11,463 | 2019 | +26.8 % | +44.6 % | View data |